Dr. Ansell on Combining CAR T-cell Therapy and Immunotherapy in Lymphomas – OncLive
Dr. Ansell on Combining CAR T-cell Therapy and Immunotherapy in LymphomasOncLiveStephen M. Ansell, MD, PhD, chair of the Lymphoma Group at Mayo Clinic, discusses the possibility of blending immunotherapy agents with chimeric antigen receptor (CAR) T-ce… Continue reading
